Benzinga | Dec 10, 2021 04:43AM EST

Piper Sandler Maintains Overweight on Blend Labs, Lowers Price Target to $13

Piper Sandler analyst Arvind Ramnani maintains Blend Labs (NYSE:BLND) with a Overweight and lowers the price target from $19 to $13.